• Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated diseases:
    Belgium Bulgaria Croatia Czechia Estonia Finland +14
  • Study on Ganaxolone for Patients with Refractory Status Epilepticus

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Croatia Czechia Denmark Finland +8
  • Study on Atezolizumab and Bevacizumab for Patients with Unresectable Liver Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study of Asciminib Treatment for Newly Diagnosed Patients with Chronic Myeloid Leukemia in Chronic Phase

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study of Cannabidiol and Risperidone for Treatment of Non-Affective Psychosis in Patients with History of Cannabis Use

    Not recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark
  • Study on the Safety and Tolerability of Olaparib in Children and Adolescents with Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark France Hungary Italy Spain
  • Study on the Safety and Effects of Nivolumab, Ipilimumab, Gemcitabine, and Paclitaxel for Patients with Advanced Pancreatic Cancer

    Not recruiting

    1 1 1 1
    Denmark
  • Study Comparing Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin to Standard Treatment for Patients with Locally Advanced Rectal Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Denmark
  • Study Comparing Patritumab Deruxtecan and Platinum-based Chemotherapy for Patients with Advanced EGFR-mutated Non-small Cell Lung Cancer After EGFR Therapy Failure

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium France Germany Italy The Netherlands +4
  • Study on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Austria Bulgaria France Germany Greece Hungary +5

powered by